Skip to main content

Day: September 17, 2024

Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025

MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced a risk of a temporary supply disruption for EGRIFTA SV® (tesamorelin for injection) in early 2025 caused by an unexpected voluntary shutdown of the Company’s contract manufacturer’s facility following an inspection by the US Food and Drug Administration (FDA), as well as the FDA review timeline to resume distribution of the product. “We are collaborating closely with our manufacturer and other stakeholders and will continue to work with the FDA to resume production of EGRIFTA SV®,” said Paul Lévesque President and CEO at Theratechnologies. “We remain confident that we will avoid any...

Continue reading

Hamilton Thorne Announces Shareholder Approval of Going Private Transaction

BEVERLY, Mass. and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology fields, today announced that the shareholders of the Company (the “Shareholders“), at a special meeting of Shareholders held earlier today (the “Meeting“), approved a statutory plan of arrangement (the “Transaction“) under the Business Corporations Act (Ontario) involving the Company and Cradle Acquisition ULC (the “Purchaser“), pursuant to which the Purchaser will acquire all of the issued and outstanding common shares of the Company (the “Shares” and each, a “Share“). A...

Continue reading

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 17, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced the results from its annual and special meeting of shareholders held earlier today. Based on the proxies received and the vote conducted at the meeting, all tabled resolutions were approved by the shareholders of the Company, including the election of the following directors for the ensuing year: Don Cilla, Brian Bloom, Theresa Matkovits, Juergen Froehlich, Armand Balboni and Prakash Gowd. Voting results for each director are summarized below:Name of Nominee Percentage of Votes For Percentage of Votes AgainstDon Cilla 27,929,188 (94.54%) 1,612,685 (5.46%)Brian...

Continue reading

Becky G and Vita Coco Build New Greenspace in Inglewood, California

New greenspace at Becky G’s elementary school enhances learning, wellness, and community connectionsBecky G Oak Street GreenspaceBecky G returned to Inglewood today to celebrate the opening of the greenspace with Vita Coco at Oak Street Elementary School.INGLEWOOD, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) — As back to school season ramps up, The Vita Coco Company, Inc. (NASDAQ: COCO) has teamed up with international recording artist, actress, activist, and Vita Coco Brand Ambassador—Becky G—to build a new greenspace at her childhood elementary school in Inglewood, California. The greenspace, opening today at Oak Street Elementary School, is a new initiative of the Company’s social impact program, the Vita Coco Project® (VCP), which focuses on empowering communities. A proud advocate for her hometown, Becky G returned to...

Continue reading

Swvl Secures $2.6 Million in New Annual Contracts in Saudi Arabia during the Third Quarter of 2024

DUBAI, United Arab Emirates, Sept. 17, 2024 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a leading technology provider for enterprise and government mobility solutions, signed multiple new contracts in Saudi Arabia during the third quarter, contributing $2.6 million in incremental annual contract value, equal to approximately ten percent of Swvl’s 2023 full year revenues. With these latest wins, Swvl’s gross profit in Saudi Arabia grew by six times the amount compared to the first quarter of 2023. This growth aligns with Swvl’s strategic focus on expanding its footprint in Saudi Arabia, its fastest growing market, offering a cutting-edge solution that addresses the transportation needs for both businesses and government entities. Through these partnerships, Swvl will deliver both fully managed...

Continue reading

Healthy Choice Wellness Corp. Announces Closing of $4.0 Million Initial Public Offering

HOLLYWOOD, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives, announced today the closing of its previously announced initial public offering of 400,000 shares of the Company’s Class A common stock, par value $0.001 per share, at an offering price of $10.00 per share, for gross proceeds of approximately $4.0 million, before deducting underwriting discounts and offering expenses (the “Offering”). In addition, HCWC has granted the underwriters a 45-day option to purchase up to an additional 60,000 shares of Class A common stock to cover over-allotments at the initial public offering price, less the underwriting discount. The shares of Class...

Continue reading

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it intends to offer shares of its Class A common stock in an underwritten public offering. Cibus also expects to grant to the underwriters of the offering a 45-day option to purchase up to an additional 15% of the shares of Class A common stock offered in the underwritten public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Certain existing institutional and accredited investors and Rory Riggs,...

Continue reading

Resolute Holdings Completes Acquisition of Majority Interest in CompoSecure

CompoSecure announces board changes with David Cote, former CEO of Honeywell, as executive chairman as well as the appointment of five new board members NEW YORK and SOMERSET, N.J., Sept. 17, 2024 (GLOBE NEWSWIRE) — Resolute Holdings I, LP and its affiliated vehicles (“Resolute”), an investment firm under the leadership of David Cote and Tom Knott, and CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure”) today announced the closing of Resolute’s acquisition of a majority interest in CompoSecure in accordance with the stock purchase agreements among Resolute and certain shareholders of CompoSecure. In conjunction with the closing, David Cote has been appointed executive chairman of the board of directors of CompoSecure and Tom Knott, Joseph DeAngelo, Roger Fradin, Mark James, and John Cote have also been appointed to the board of directors. Pursuant...

Continue reading

DarkPulse, Inc. Completes Acquisition of Certain Assets of Optilan UK Ltd Including India and Turkey Subsidiaries

DarkPulse secures global operations and engineering capabilities in India and Turkey as part its Global Strategy HOUSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) — DarkPulse, Inc. (OTC: DPLS) (“DarkPulse”, “DPLS”, or “the Company”) today announced the closing of the acquisition of certain assets of Optilan UK Ltd including two operating subsidiaries. The subsidiaries acquired are Optilan India Pvt Ltd, a major engineering group that designed multiple installations across the globe including security, rail, oil and gas, telecoms and, most importantly, distributed fiber optic sensor systems (DFOSS). The second entity acquired is Optilan Communications & Security Systems Ltd (Turkey) who has played a key role in projects including the Trans-Anatolian Natural Gas Pipeline (TANAP) installation as well as maintenance services...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from September 9 to 13, 2024

PRESS RELEASE Arcueil, September 17, 2024 Declaration of transactions on own shares conducted from September 9 to 13, 2024 Within the framework of the authorizations granted by the General Assembly on February 9, 2024, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from September 9 to 13, 2024 (excluding the liquidity contract):Nom de l’émetteur Code Identifiant de l’émetteur Jour de la transaction Code identifiant de l’instrument financier Volume total journalier (en nombre d’actions) Prix pondéré moyen journalier d’acquisition des actions MarchéAramis Group 9695002Q984W0T41WB42 2024-09-12 FR0014003U94 851 5,2959 XPARAramis Group ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.